gaugene

Gaugene (Beijing Zhizhen Biotechnology Co., Ltd. / 知真生物), founded in 2017 and headquartered in Beijing, China, develops and supplies flow cytometry instruments and reagents for the in-vitro diagnostics and life-sciences research market. Its analyzers use high-power lasers and high-sensitivity multi-color fluorescence detection for clinical hematology diagnosis, single-cell analysis, protein screening, and clinical-indicator discovery. Gaugene is a venture-backed diagnostics-hardware and reagents maker rather than an API provider; as of this enrichment pass it publishes no reachable public developer portal, API documentation, or machine-readable API surface (its apex domain does not resolve and www.gaugene.com returns a 502). It was added to the API Evangelist network as a portfolio-lead stub via Qiming Venture Partners.

gaugene is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Diagnostics, Flow Cytometry, and Medical Devices.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyDiagnosticsFlow CytometryMedical DevicesLife SciencesChina

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/gaugene: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: gaugene
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/gaugene.png
name: gaugene
description: Gaugene (Beijing Zhizhen Biotechnology Co., Ltd. / 知真生物), founded in 2017 and headquartered in Beijing, China,
  develops and supplies flow cytometry instruments and reagents for the in-vitro diagnostics and life-sciences research market.
  Its analyzers use high-power lasers and high-sensitivity multi-color fluorescence detection for clinical hematology diagnosis,
  single-cell analysis, protein screening, and clinical-indicator discovery. Gaugene is a venture-backed diagnostics-hardware
  and reagents maker rather than an API provider; as of this enrichment pass it publishes no reachable public developer portal,
  API documentation, or machine-readable API surface (its apex domain does not resolve and www.gaugene.com returns a 502).
  It was added to the API Evangelist network as a portfolio-lead stub via Qiming Venture Partners.
url: https://raw.githubusercontent.com/api-evangelist/gaugene/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Diagnostics
- Flow Cytometry
- Medical Devices
- Life Sciences
- China
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://gaugene.com
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence